Form D · Biotechnology

Otonomy, Inc.

San Diego, CA · CIK 0001493566

Offering snapshot reported Jun 2, 2011 · SEC filing

Reported sold
$24.2M
Offering amount: $38.8M
Investors reported
13
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Aug 26, 2010
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$12.1M$24.2MSep 3, 2010: $10,037,465.00Sep 3, 2010Jun 2, 2011: $24,214,701.00Jun 2, 2011

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

  • Reported sold$10,037,465 → $24,214,701
  • Reported investors10 → 13

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Jun 2, 2011Amendment$24,214,701$14,177,236vs Sep 3, 201013SEC filing
Sep 3, 2010Initial$10,037,465No comparison10SEC filing
Jun 9, 2010Initial$10,567,046No comparison3SEC filing

Offering details

Securities
Equity
Exemptions
06
Duration over one year
Yes
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-147275
$14,125,289.53 previously sold on May 18, 2011

Source: Form D, filed Jun 2, 2011. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Peter Bisgaard Director
Paul Cayer Executive
Brian Dovey Director
Douglas Downs Executive
Jeffrey Harris Director
Jeffrey Harris, M.D., Ph.D. Director
Carl Le Bel Executive
Carl Le Bel, Ph.D. Executive
Jay Lichter Director
Jay Lichter, Ph.D. Director, Executive
John Mc Kearn Director
Heather Preston Director
Court Turner Director
David Weber Director, Executive
Gerald Wroblewski Executive

Issuer details

Industry: Biotechnology (See others in industry)

Address:
5626 Oberlin Drive, Suite 100
San Diego, CA, 92121